What is the address of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE?

The registered office of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE is located at Acaciadreef 31, 3140 Keerbergen.

Is DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE still active?

Yes. According to the CBE (16 September 2026) DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE is active, legal situation “Normale toestand”, started on 3 December 2002.

Is DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE registered on Peppol?

No, DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE?

The enterprise number of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE is BE0478919979.

When was DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE founded?

DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE was founded on 3 December 2002.

Who are the directors of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE?

According to the 2025 annual accounts, the directors of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE are: Ann De Corte, Georges Blinder.

Is DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 December 2002; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE make in 2025?

DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE posted a profit after taxes of € 19,181 in financial year 2025.

What is the revenue of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE?

As a small company, DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 9,996.

DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE (Private Limited)

Dossier DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE, printed on 16 September 2026 from databakkes.be/en/0478919979/dr-blinder-dr-de-corte-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE from Keerbergen, company number BE0478919979, closed financial year 2025 with a result of € 19,181 after tax. For that financial year DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE recorded a gross margin of € 9,996 and equity of € 606,697. Compared with financial year 2024, the result moved from € 479 to € 19,181. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 606,697

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 19,181

▲ € 18,703 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 147,477

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 494,697.

People and assets in 2025

Vehicles and equipment

€ 1,346

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,337

▼ 28% vs 2024

€ 13,480 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 30

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,997

▼ 62% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 82,943 Gross margin 2022: € 82,943 First fiscal year in the series	€ 152,339 Gross margin 2023: € 152,339 ▲ 84% vs 2022 (€ 82,943) Favourable step	€ 12,683 Gross margin 2024: € 12,683 ▼ 92% vs 2023 (€ 152,339) Unfavourable step	€ 9,996 Gross margin 2025: € 9,996 ▼ 21% vs 2024 (€ 12,683) Unfavourable step	▼ 21%
Profit after taxes	€ 18,063 Profit after taxes 2022: € 18,063 First fiscal year in the series	€ 89,248 Profit after taxes 2023: € 89,248 ▲ € 71,184 vs 2022 (€ 18,063) Favourable step	€ 479 Profit after taxes 2024: € 479 ▼ 99% vs 2023 (€ 89,248) Unfavourable step	€ 19,181 Profit after taxes 2025: € 19,181 ▲ € 18,703 vs 2024 (€ 479) Favourable step	▲ € 18,703
Equity	€ 497,789 Equity 2022: € 497,789 First fiscal year in the series	€ 587,037 Equity 2023: € 587,037 ▲ 18% vs 2022 (€ 497,789) Favourable step	€ 587,515 Equity 2024: € 587,515 Unchanged (€ 587,037) Favourable step	€ 606,697 Equity 2025: € 606,697 ▲ 3% vs 2024 (€ 587,515) Favourable step	▲ 3%
Total debts	€ 182,990 Total debts 2022: € 182,990 First fiscal year in the series	€ 175,189 Total debts 2023: € 175,189 ▼ 4% vs 2022 (€ 182,990) Favourable step	€ 173,036 Total debts 2024: € 173,036 ▼ 1% vs 2023 (€ 175,189) Favourable step	€ 94,249 Total debts 2025: € 94,249 ▼ 46% vs 2024 (€ 173,036) Favourable step	▼ 46%
Cash	€ 243,904 Cash 2022: € 243,904 First fiscal year in the series	€ 745,138 Cash 2023: € 745,138 ▲ 206% vs 2022 (€ 243,904) Favourable step	€ 343,765 Cash 2024: € 343,765 ▼ 54% vs 2023 (€ 745,138) Unfavourable step	€ 147,477 Cash 2025: € 147,477 ▼ 57% vs 2024 (€ 343,765) Unfavourable step	▼ 57%
Land & buildings	€ 407,128 Land & buildings 2022: € 407,128 First fiscal year in the series	€ 0 Land & buildings 2023: € 0 ▼ 100% vs 2022 (€ 407,128) Unchanged	-	-
Retained profit	€ 385,789 Retained profit 2022: € 385,789 First fiscal year in the series	€ 475,037 Retained profit 2023: € 475,037 ▲ 23% vs 2022 (€ 385,789) Favourable step	€ 475,515 Retained profit 2024: € 475,515 Unchanged (€ 475,037) Favourable step	€ 494,697 Retained profit 2025: € 494,697 ▲ 4% vs 2024 (€ 475,515) Favourable step	▲ 4%
Bank debt	€ 69,259 Bank debt 2022: € 69,259 First fiscal year in the series	€ 57,994 Bank debt 2023: € 57,994 ▼ 16% vs 2022 (€ 69,259) Favourable step	€ 46,034 Bank debt 2024: € 46,034 ▼ 21% vs 2023 (€ 57,994) Favourable step	€ 33,337 Bank debt 2025: € 33,337 ▼ 28% vs 2024 (€ 46,034) Favourable step	▼ 28%
Balance sheet total	€ 680,779 Balance sheet total 2022: € 680,779 First fiscal year in the series	€ 762,225 Balance sheet total 2023: € 762,225 ▲ 12% vs 2022 (€ 680,779) Unchanged	€ 760,551 Balance sheet total 2024: € 760,551 Unchanged (€ 762,225) Unchanged	€ 700,946 Balance sheet total 2025: € 700,946 ▼ 8% vs 2024 (€ 760,551) Unchanged	▼ 8%

Key figures of DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE?

What happened at DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 19,181 (▲ € 18,703 vs 2024). Source: NBB ↗
Dec 3, 2002 New establishment in Keerbergen. KBO
Dec 3, 2002 Start of the company according to the CBE. KBO

In short

From € 18,063 profit in 2022 to € 19,181 profit in 2025.

Paid € 64,400 in corporate taxes since 2022.

Best year ever: 2023, with € 89,248 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE? We notify you, reason included.

Follow DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ann De Corte Georges Blinder

DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE

Behind DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE are Ann De Corte and Georges Blinder.

See the full network in the app

Directors

According to the 2025 annual accounts

Ann De Corte

Director

Georges Blinder

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Acaciadreef 31

3140 Keerbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0478.919.979
VAT number: BE 0478.919.979
Registered office: Acaciadreef 31, 3140 Keerbergen
Names & denominations: DR.BLINDER - DR.DE CORTE, GASTRO - ENTEROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 December 2002
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗